Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,370 | 84 | 56.6% |
| Travel and Lodging | $3,353 | 17 | 43.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $6,334 | 85 | $0 (2024) |
| Boston Scientific Corporation | $1,143 | 6 | $0 (2022) |
| Abbott Laboratories | $114.41 | 3 | $0 (2024) |
| ABBVIE INC. | $50.38 | 3 | $0 (2024) |
| Indivior Inc. | $38.12 | 2 | $0 (2024) |
| Nevro Corp. | $22.03 | 1 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.18 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,253 | 24 | Medtronic, Inc. ($1,140) |
| 2023 | $4,259 | 56 | Medtronic, Inc. ($4,245) |
| 2022 | $2,110 | 18 | Boston Scientific Corporation ($1,143) |
| 2021 | $100.64 | 3 | Medtronic, Inc. ($100.64) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $103.52 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/21/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $72.77 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/10/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $71.80 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/25/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $40.53 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/25/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/24/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $57.12 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/12/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $92.29 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/29/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $70.45 | General |
| Category: Drug Infusion Systems | ||||||
| 08/15/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $95.28 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $81.18 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/11/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $56.86 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/11/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/25/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $43.53 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: OUD | ||||||
| 05/01/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $67.55 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/01/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: OUD | ||||||
| 04/25/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $74.36 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/19/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Drug Infusion Systems | ||||||
| 03/28/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $94.76 | General |
| Category: Drug Infusion Systems | ||||||
| 03/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/11/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $38.13 | General |
| Category: Neuromodulation | ||||||
| 02/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/18/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $59.38 | General |
| Category: Drug Infusion Systems | ||||||
| 12/29/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,063 | 3,100 | $553,225 | $124,320 |
| 2022 | 10 | 223 | 543 | $182,901 | $19,293 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 233 | 547 | $144,758 | $52,566 | 36.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 48 | 57 | $53,695 | $13,142 | 24.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 15 | 15 | $28,500 | $7,744 | 27.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 33 | 37 | $44,278 | $7,060 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 89 | $14,883 | $6,176 | 41.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 15 | 15 | $15,000 | $4,244 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $16,189 | $3,828 | 23.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 18 | 20 | $24,861 | $3,652 | 14.7% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 15 | 20 | $29,085 | $3,493 | 12.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 20 | 23 | $23,978 | $3,166 | 13.2% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 14 | 14 | $10,710 | $3,066 | 28.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 18 | 20 | $15,281 | $1,941 | 12.7% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 15 | 20 | $15,634 | $1,850 | 11.8% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 18 | 19 | $5,700 | $1,691 | 29.7% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 16 | 16 | $4,000 | $1,636 | 40.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 29 | 35 | $11,025 | $1,587 | 14.4% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 24 | 26 | $12,909 | $1,244 | 9.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 20 | $9,659 | $1,006 | 10.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 36 | 166 | $5,312 | $995.45 | 18.7% |
| 20551 | Injection into tendon at attachment to bone or muscle | Office | 2023 | 18 | 22 | $7,480 | $993.93 | 13.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 14 | 14 | $12,264 | $852.60 | 7.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 60 | 67 | $3,450 | $816.41 | 23.7% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 21 | 22 | $3,850 | $590.92 | 15.3% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 103 | 158 | $19,080 | $587.48 | 3.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 46 | 255 | $8,193 | $196.76 | 2.4% |
About Dr. Chad Jensen, DO
Dr. Chad Jensen, DO is a Anesthesiology healthcare provider based in Elko, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2017. The National Provider Identifier (NPI) number assigned to this provider is 1164951778.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chad Jensen, DO has received a total of $7,723 in payments from pharmaceutical and medical device companies, with $1,253 received in 2024. These payments were reported across 101 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($4,370).
As a Medicare-enrolled provider, Jensen has provided services to 1,286 Medicare beneficiaries, totaling 3,643 services with total Medicare billing of $143,613. Data is available for 2 years (2022–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine
- Location Elko, NV
- Active Since 06/07/2017
- Last Updated 02/12/2024
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1164951778
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $3,440
- SYNCHROMEDII (Device) $1,655
- VANTA ADAPTIVESTIM (Device) $1,138
- WaveWriter Alpha Prime 16 (Device) $1,055
- INTELLIS (Device) $100.64
- General - Pain Management (Device) $87.67
- PROCLAIM (Device) $76.28
- ETERNA (Device) $38.13
- SUBLOCADE (Drug) $38.12
- BOTOX (Biological) $23.63
- Omnia (Device) $22.03
- NURTEC ODT (Drug) $21.18
- UBRELVY (Drug) $13.65
- QULIPTA (Drug) $13.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.